BACKGROUND: Limited information exists regarding the natural progression of health-related quality of life (HRQOL) in the general population, as most research has been cross-sectional or has followed populations with specific medical conditions. Such norms are important to establish, because the effect of any intervention may be confounded by changes due to the natural progression of HRQOL over time. METHODS: Participants were randomly selected from 9 Canadian cities and surrounding rural areas. Changes in the eight domains and 2 summary component scores of the Medical Outcomes Study 36-item short form (SF-36) were examined over a 5 year period (1996/1997-2001/2002). Mean changes were calculated for men and women within 10 year age categories. Multiple imputation was used to adjust for potential selection bias due to missing data. RESULTS: The baseline sample included 6539 women and 2884 men. Loss to follow-up was 17% for women and 23% for men. Mean changes tended to be small, but there was an overall trend towards decreasing HRQOL over time. Changes were more pronounced in the older age groups and in the physically oriented domains. Younger age groups tended towards small mean improvements, particularly in the mentally oriented domains. Large standard errors suggest that on an individual level, large improvements in some participants are balanced by large declines in others. CONCLUSION: In general, the HRQOL of Canadians appears relatively stable over a 5 year period. However, care should be taken when assessing HRQOL longitudinally in certain age or gender groups, as changes associated with an intervention can potentially be confounded by the natural progression of HRQOL.
BACKGROUND: Limited information exists regarding the natural progression of health-related quality of life (HRQOL) in the general population, as most research has been cross-sectional or has followed populations with specific medical conditions. Such norms are important to establish, because the effect of any intervention may be confounded by changes due to the natural progression of HRQOL over time. METHODS:Participants were randomly selected from 9 Canadian cities and surrounding rural areas. Changes in the eight domains and 2 summary component scores of the Medical Outcomes Study 36-item short form (SF-36) were examined over a 5 year period (1996/1997-2001/2002). Mean changes were calculated for men and women within 10 year age categories. Multiple imputation was used to adjust for potential selection bias due to missing data. RESULTS: The baseline sample included 6539 women and 2884 men. Loss to follow-up was 17% for women and 23% for men. Mean changes tended to be small, but there was an overall trend towards decreasing HRQOL over time. Changes were more pronounced in the older age groups and in the physically oriented domains. Younger age groups tended towards small mean improvements, particularly in the mentally oriented domains. Large standard errors suggest that on an individual level, large improvements in some participants are balanced by large declines in others. CONCLUSION: In general, the HRQOL of Canadians appears relatively stable over a 5 year period. However, care should be taken when assessing HRQOL longitudinally in certain age or gender groups, as changes associated with an intervention can potentially be confounded by the natural progression of HRQOL.
Authors: Wilma M Hopman; Claudie Berger; Lawrence Joseph; Tanveer Towheed; Tassos Anastassiades; Alan Tenenhouse; Suzette Poliquin; Jacques P Brown; Timothy M Murray; Jonathan D Adachi; David A Hanley; Emmanuel A Papadimitropoulos Journal: Can J Public Health Date: 2002 May-Jun
Authors: W M Hopman; T Towheed; T Anastassiades; A Tenenhouse; S Poliquin; C Berger; L Joseph; J P Brown; T M Murray; J D Adachi; D A Hanley; E Papadimitropoulos Journal: CMAJ Date: 2000-08-08 Impact factor: 8.262
Authors: Wilma M Hopman; Claudie Berger; Lawrence Joseph; Tanveer Towheed; Elizabeth vandenKerkhof; Tassos Anastassiades; Ann Cranney; Jonathan D Adachi; George Loannidis; Suzette Poliquin; Jacques P Brown; Timothy M Murray; David A Hanley; Emmanuel A Papadimitropoulos; Alan Tenenhouse Journal: Can J Public Health Date: 2004 Sep-Oct
Authors: P Panopalis; M Petri; S Manzi; D A Isenberg; C Gordon; J-L Senecal; J R Penrod; L Joseph; Y St Pierre; C Pineau; P R Fortin; N Sutcliffe; J-R Goulet; D Choquette; T Grodzicky; J M Esdaile; A E Clarke Journal: Rheumatology (Oxford) Date: 2005-03-09 Impact factor: 7.580
Authors: Peter R van Dijk; Susan Jj Logtenberg; Klaas H Groenier; Joost C Keers; Henk Jg Bilo; Nanne Kleefstra Journal: World J Diabetes Date: 2014-08-15
Authors: Wilma M Hopman; Claudie Berger; Lawrence Joseph; Wei Zhou; Jerilynn C Prior; Tanveer Towheed; Tassos Anastassiades; Jonathan D Adachi; David A Hanley; Emmanuel A Papadimitropoulos; Susan Kirkland; Stephanie M Kaiser; Robert G Josse; David Goltzman Journal: Qual Life Res Date: 2014-06-13 Impact factor: 4.147
Authors: Julie Lemieux; Michael D Brundage; Wendy R Parulekar; Paul E Goss; James N Ingle; Kathleen I Pritchard; Paul Celano; Hyman Muss; Julie Gralow; Kathrin Strasser-Weippl; Kate Whelan; Dongsheng Tu; Timothy J Whelan Journal: J Clin Oncol Date: 2018-01-12 Impact factor: 44.544
Authors: Wilma M Hopman; Claudie Berger; Lawrence Joseph; Susan I Barr; Yongjun Gao; Jerilynn C Prior; Suzette Poliquin; Tanveer Towheed; Tassos Anastassiades Journal: Qual Life Res Date: 2007-10-24 Impact factor: 4.147
Authors: Frank Peters-Klimm; Stephen Campbell; Katja Hermann; Cornelia U Kunz; Thomas Müller-Tasch; Joachim Szecsenyi Journal: Trials Date: 2010-05-17 Impact factor: 2.279
Authors: D Marrero; Q Pan; E Barrett-Connor; M de Groot; P Zhang; C Percy; H Florez; R Ackermann; M Montez; R R Rubin Journal: Qual Life Res Date: 2013-05-26 Impact factor: 4.147
Authors: J A Palacio-Vieira; E Villalonga-Olives; J M Valderas; M Espallargues; M Herdman; S Berra; J Alonso; L Rajmil Journal: Qual Life Res Date: 2008-10-18 Impact factor: 4.147